4//SEC Filing
Bell Graeme 4
Accession 0001209191-17-059054
CIK 0001652130other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 11:54 AM ET
Size
4.8 KB
Accession
0001209191-17-059054
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2017-11-03$22.04/sh+5,000$110,217→ 13,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.15.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001643757
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 11:54 AM ET
- Size
- 4.8 KB